HomeSearchGlobal LocationsContact UsGenzyme Websites
About GenzymeOur ResearchOur ProductsOur Commitment
Genzyme

Patients
Unmet Medical Needs
Free Drug Programs
Humanitarian Programs
Cost of Treatment
Patient Organizations
Community
Environment

Our Commitment to Patients

At Genzyme, improving the lives of patients is and always will be our top priority. We exist to innovate on behalf of people with debilitating diseases. By seeking out unmet medical needs and developing solutions, we provide hope to patients who otherwise would have no treatment options. This patient focus pervades everything we do.

Our commitment to patients is about much more than developing and delivering products. It is also about ensuring that patients have access to our life-saving therapies regardless of their location or financial circumstances. We work with governments around the world to secure approvals for our products and we provide a wide range of support services to patients. We have a strong presence in developing countries, where we provide free medicine and help to build sustainable health-care systems.

Genzyme's commitment to patients extends beyond the areas of our medical focus. In an effort to improve global health more broadly, we have formed partnerships that will enable us to advance treatments for neglected diseases such as African sleeping sickness and malaria, which affect developing countries and impede their progress. Genzyme also helps patients impacted by disasters around the world by donating products, supporting the rebuilding of health-care infrastructure, and matching employee donations to relief organizations.


Highlight

Gaucher Initiative Helps Patients in the Developing World

The Gaucher Initiative is a humanitarian program through which Genzyme provides Cerezyme to Gaucher patients in developing countries. It is one of several charitable access programs sponsored by the company. Read more about the Gaucher Initiative.


Terms and Conditions of Use | Privacy Policy | © 2002-2012 Genzyme Corporation, a Sanofi company. All rights reserved.